Amoeba SA (0RAE) AI Stock Analysis

Amoeba SA

(LSE:0RAE)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Proprietary biotechnology platformA proprietary amoeba-based technology platform gives Amoéba a defined foundation for product development rather than relying solely on generic inputs. If successfully developed and approved, the platform could support differentiated biological solutions across multiple applications over the medium term.

Negative Factors

Revenue collapseRevenue collapsing to zero demonstrates that the company has not yet established dependable commercial scale. Without recurring sales, product development and regulatory investments remain difficult to fund internally, while the absence of revenue also limits evidence that the platform can convert into a sustainable operating business.

Amoeba SA (0RAE) vs. iShares MSCI United Kingdom ETF (EWC)

Market Cap: EUR 33.06M
Dividend Yield: ―
Average Volume (3M): 7,240
Price to Earnings (P/E): -1.8
Beta (1Y): 1.46
Revenue Growth: ―
EPS Growth: -10.52%
Country: UK
Employees: 23
Sector: General
Sector Strength: 55
Industry: Agricultural Inputs

Amoeba SA Business Overview & Revenue Model

Company Description

Amoéba S.A. focuses on the development and commercialization of anti-microbial and anti-fungal products. The company's primary innovation centers on harnessing the unique properties of the Willaertia magna C2c Maky amoeba, which it is applying across...

Amoeba SA Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

GB:0RAE against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FR:COH	73Outperform	EUR 46.51M	15.43	12.54%	0.98%	8.58%	-18.77%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
FR:ALATA	50Neutral	EUR 65.77M	-7.55	-101.20%	―	66.67%	74.66%
FR:BIG	38Underperform	EUR 1.19M	-0.00	-403.52%	―	-1.22%	-101445.24%
FR:ALCLA	32Underperform	EUR 28.31M	6.18	10.38%	―	―	―

* General Sector Average

Performance Comparison

GB:0RAE and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
GB:0RAE	Amoeba SA	0.26	-0.82	-76.17%
FR:ALJXR	Archos	0.26	0.07	35.79%
FR:ALATA	Atari SA	15.47	-12.33	-44.35%
FR:ALCLA	Claranova SA	0.50	-1.19	-70.59%
FR:BIG	Bigben Interactive	0.07	-1.00	-93.91%
FR:COH	Coheris	8.18	-5.83	-41.61%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Amoeba SA AI Stock Analysis